NOS2 and breast carcinoma: Although MCF-7 and MDA-231 breast carcinoma cells express both iNOS and eNOS isoforms, these results suggested that iNOS is uncoupled since the iNOS selective inhibitor 1400 W impaired the L-sepiapterin-induced cGMP levels [35].